{"transactions":[{"id":1979677,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2023-03-02T14:42:23.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":690,"price":12.38,"value":8542.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":62824,"source":{"system":"sec-edgar","filing":"0001367644-23-000056","document":"wf-form4_167778612811435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764423000056/wf-form4_167778612811435.xml","form_type":"4"}},{"id":1990487,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2023-02-27T20:24:01.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":654,"price":13.71,"value":8966.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":63514,"source":{"system":"sec-edgar","filing":"0001367644-23-000038","document":"wf-form4_167754742435549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764423000038/wf-form4_167754742435549.xml","form_type":"4"}},{"id":1990486,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2023-02-27T20:24:01.000Z","date":"2023-02-23","kind":"tax_withholding","acquired":false,"shares":352,"price":14.3,"value":5033.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":64168,"source":{"system":"sec-edgar","filing":"0001367644-23-000038","document":"wf-form4_167754742435549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764423000038/wf-form4_167754742435549.xml","form_type":"4"}},{"id":2022783,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2023-02-10T20:35:47.000Z","date":"2023-02-08","kind":"tax_withholding","acquired":false,"shares":1438,"price":13.25,"value":19053.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":64520,"source":{"system":"sec-edgar","filing":"0001367644-23-000016","document":"wf-form4_167607932918775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764423000016/wf-form4_167607932918775.xml","form_type":"4"}},{"id":2022782,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2023-02-10T20:35:47.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":61,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 3,723 shares of common stock, which is in excess of the 3,662 shares previously reported on February 25, 2020."}],"balance_after":65958,"source":{"system":"sec-edgar","filing":"0001367644-23-000016","document":"wf-form4_167607932918775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764423000016/wf-form4_167607932918775.xml","form_type":"4"}},{"id":2360934,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2022-03-02T18:45:02.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":24164,"price":41.38,"value":999906.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":24164,"derivative":{"exercise_price":41.38,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":24164},"source":{"system":"sec-edgar","filing":"0001367644-22-000040","document":"wf-form4_164626467480687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764422000040/wf-form4_164626467480687.xml","form_type":"4"}},{"id":2360933,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2022-03-02T18:45:02.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":561,"price":39.64,"value":22238.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":65897,"source":{"system":"sec-edgar","filing":"0001367644-22-000040","document":"wf-form4_164626467480687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764422000040/wf-form4_164626467480687.xml","form_type":"4"}},{"id":2360932,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2022-03-02T18:45:02.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":12083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":66458,"source":{"system":"sec-edgar","filing":"0001367644-22-000040","document":"wf-form4_164626467480687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764422000040/wf-form4_164626467480687.xml","form_type":"4"}},{"id":2360931,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2022-03-02T18:45:02.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":24167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest either in three equal annual installments beginning on the day prior to the first anniversary of the date of grant (6,042 shares) or on the day prior to the second anniversary date of the grant (18,125 shares), assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":54375,"source":{"system":"sec-edgar","filing":"0001367644-22-000040","document":"wf-form4_164626467480687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764422000040/wf-form4_164626467480687.xml","form_type":"4"}},{"id":2372182,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2022-02-25T17:19:34.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":590,"price":42.47,"value":25057.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":30208,"source":{"system":"sec-edgar","filing":"0001367644-22-000034","document":"wf-form4_164582755230958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764422000034/wf-form4_164582755230958.xml","form_type":"4"}},{"id":2372181,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2022-02-25T17:19:34.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":344,"price":42.23,"value":14527.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":30798,"source":{"system":"sec-edgar","filing":"0001367644-22-000034","document":"wf-form4_164582755230958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764422000034/wf-form4_164582755230958.xml","form_type":"4"}},{"id":2374914,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2022-02-24T18:47:18.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":1616,"price":42.23,"value":68243.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":31142,"source":{"system":"sec-edgar","filing":"0001367644-22-000014","document":"wf-form4_164574640464379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764422000014/wf-form4_164574640464379.xml","form_type":"4"}},{"id":2374913,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2022-02-24T18:47:18.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":1258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 4,741 shares of common stock, which is in excess of the 3,483 shares previously reported on February 28, 2019."}],"balance_after":32758,"source":{"system":"sec-edgar","filing":"0001367644-22-000014","document":"wf-form4_164574640464379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764422000014/wf-form4_164574640464379.xml","form_type":"4"}},{"id":2829866,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-26T17:14:45.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":10696,"price":93.49,"value":999969.04,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":10696,"derivative":{"exercise_price":93.49,"expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":10696},"source":{"system":"sec-edgar","filing":"0001367644-21-000042","document":"wf-form4_161437759770567.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764421000042/wf-form4_161437759770567.xml","form_type":"4"}},{"id":2829865,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2021-02-26T17:14:45.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":561,"price":97.15,"value":54501.15,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":31500,"source":{"system":"sec-edgar","filing":"0001367644-21-000042","document":"wf-form4_161437759770567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764421000042/wf-form4_161437759770567.xml","form_type":"4"}},{"id":2829864,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2021-02-26T17:14:45.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":649,"price":97.15,"value":63050.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":32061,"source":{"system":"sec-edgar","filing":"0001367644-21-000042","document":"wf-form4_161437759770567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764421000042/wf-form4_161437759770567.xml","form_type":"4"}},{"id":2829863,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2021-02-26T17:14:45.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":619,"price":93.49,"value":57870.31,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":32710,"source":{"system":"sec-edgar","filing":"0001367644-21-000042","document":"wf-form4_161437759770567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764421000042/wf-form4_161437759770567.xml","form_type":"4"}},{"id":2829862,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2021-02-26T17:14:45.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":2674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":33329,"source":{"system":"sec-edgar","filing":"0001367644-21-000042","document":"wf-form4_161437759770567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764421000042/wf-form4_161437759770567.xml","form_type":"4"}},{"id":2829861,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2021-02-26T17:14:45.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":2674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":30655,"source":{"system":"sec-edgar","filing":"0001367644-21-000042","document":"wf-form4_161437759770567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764421000042/wf-form4_161437759770567.xml","form_type":"4"}},{"id":2866762,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2021-02-11T21:22:57.000Z","date":"2021-02-09","kind":"tax_withholding","acquired":false,"shares":2042,"price":123.45,"value":252084.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs."}],"balance_after":27981,"source":{"system":"sec-edgar","filing":"0001367644-21-000015","document":"wf-form4_161309656087627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764421000015/wf-form4_161309656087627.xml","form_type":"4"}},{"id":2866761,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2021-02-11T21:22:57.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":2014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of Performance Stock Units (\"PSUs\") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 6,043 shares of common stock, which is in excess of the 4,029 shares previously reported on March 1, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of Performance Stock Units (\"PSUs\") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 6,043 shares of common stock, which is in excess of the 4,029 shares previously reported on March 1, 2018."}],"balance_after":30023,"source":{"system":"sec-edgar","filing":"0001367644-21-000015","document":"wf-form4_161309656087627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764421000015/wf-form4_161309656087627.xml","form_type":"4"}},{"id":3152839,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2020-05-12T16:30:08.000Z","date":"2020-05-08","kind":"tax_withholding","acquired":false,"shares":237,"price":79.25,"value":18782.25,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":28009,"source":{"system":"sec-edgar","filing":"0001367644-20-000059","document":"wf-form4_158931538972314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764420000059/wf-form4_158931538972314.xml","form_type":"4"}},{"id":3244011,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-02-27T21:24:40.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":14648,"price":61.44,"value":899973.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company."}],"balance_after":43225,"derivative":{"exercise_price":61.44,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":14648},"source":{"system":"sec-edgar","filing":"0001367644-20-000020","document":"wf-form4_158285666341902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764420000020/wf-form4_158285666341902.xml","form_type":"4"}},{"id":3244010,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2020-02-27T21:24:40.000Z","date":"2020-02-27","kind":"tax_withholding","acquired":false,"shares":387,"price":58.42,"value":22608.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":28246,"source":{"system":"sec-edgar","filing":"0001367644-20-000020","document":"wf-form4_158285666341902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764420000020/wf-form4_158285666341902.xml","form_type":"4"}},{"id":3244009,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2020-02-27T21:24:40.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":381,"price":59.91,"value":22825.71,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":28633,"source":{"system":"sec-edgar","filing":"0001367644-20-000020","document":"wf-form4_158285666341902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764420000020/wf-form4_158285666341902.xml","form_type":"4"}},{"id":3244008,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2020-02-27T21:24:40.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":498,"price":59.91,"value":29835.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":29014,"source":{"system":"sec-edgar","filing":"0001367644-20-000020","document":"wf-form4_158285666341902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764420000020/wf-form4_158285666341902.xml","form_type":"4"}},{"id":3244007,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2020-02-27T21:24:40.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":3662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the three year period 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period."}],"balance_after":29512,"source":{"system":"sec-edgar","filing":"0001367644-20-000020","document":"wf-form4_158285666341902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764420000020/wf-form4_158285666341902.xml","form_type":"4"}},{"id":3244006,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2020-02-27T21:24:40.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":3662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":25850,"source":{"system":"sec-edgar","filing":"0001367644-20-000020","document":"wf-form4_158285666341902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000136764420000020/wf-form4_158285666341902.xml","form_type":"4"}},{"id":3531732,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2019-05-10T17:18:01.000Z","date":"2019-05-08","kind":"tax_withholding","acquired":false,"shares":237,"price":47.49,"value":11255.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":22188,"source":{"system":"sec-edgar","filing":"0001567619-19-010449","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000156761919010449/doc1.xml","form_type":"4"}},{"id":3626505,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-28T19:29:45.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":13929,"price":61.01,"value":849808.29,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":13929,"derivative":{"exercise_price":61.01,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":13929},"source":{"system":"sec-edgar","filing":"0001567619-19-005676","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000156761919005676/doc1.xml","form_type":"4"}},{"id":3626504,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2019-02-28T19:29:45.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":540,"price":58.71,"value":31703.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":22425,"source":{"system":"sec-edgar","filing":"0001567619-19-005676","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000156761919005676/doc1.xml","form_type":"4"}},{"id":3626503,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2019-02-28T19:29:45.000Z","date":"2019-02-27","kind":"tax_withholding","acquired":false,"shares":387,"price":57.98,"value":22438.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":22965,"source":{"system":"sec-edgar","filing":"0001567619-19-005676","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000156761919005676/doc1.xml","form_type":"4"}},{"id":3626502,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2019-02-28T19:29:45.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":3483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period."}],"balance_after":23352,"source":{"system":"sec-edgar","filing":"0001567619-19-005676","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000156761919005676/doc1.xml","form_type":"4"}},{"id":3626501,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2019-02-28T19:29:45.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":3483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":19869,"source":{"system":"sec-edgar","filing":"0001567619-19-005676","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000156761919005676/doc1.xml","form_type":"4"}},{"id":3626500,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2019-02-28T19:29:45.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":448,"price":61.01,"value":27332.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":16386,"source":{"system":"sec-edgar","filing":"0001567619-19-005676","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000156761919005676/doc1.xml","form_type":"4"}},{"id":3939094,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2018-05-10T16:39:14.000Z","date":"2018-05-08","kind":"tax_withholding","acquired":false,"shares":237,"price":48.33,"value":11454.21,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":16834,"source":{"system":"sec-edgar","filing":"0001140361-18-022813","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000114036118022813/doc1.xml","form_type":"4"}},{"id":4024135,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-01T17:05:15.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":16116,"price":49.64,"value":799998.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments on February 26, 2019, February 26, 2020 and February 26, 2021."}],"balance_after":16116,"derivative":{"exercise_price":49.64,"expiration_date":"2025-02-26","underlying":"Common Stock","underlying_shares":16116},"source":{"system":"sec-edgar","filing":"0001140361-18-011289","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000114036118011289/doc1.xml","form_type":"4"}},{"id":4024134,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2018-03-01T17:05:15.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":540,"price":49.97,"value":26983.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":17071,"source":{"system":"sec-edgar","filing":"0001140361-18-011289","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000114036118011289/doc1.xml","form_type":"4"}},{"id":4024133,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2018-03-01T17:05:15.000Z","date":"2018-02-27","kind":"tax_withholding","acquired":false,"shares":387,"price":49.64,"value":19210.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":17611,"source":{"system":"sec-edgar","filing":"0001140361-18-011289","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000114036118011289/doc1.xml","form_type":"4"}},{"id":4024132,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2018-03-01T17:05:15.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":4029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period."}],"balance_after":17998,"source":{"system":"sec-edgar","filing":"0001140361-18-011289","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000114036118011289/doc1.xml","form_type":"4"}},{"id":4024131,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":116151,"kind":"person","name":"Strei Katherine","position":1,"cik":"0001709639","reported_name":"Strei Katherine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief HR Officer"}}],"security":"Common Stock","published_at":"2018-03-01T17:05:15.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":4029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":13969,"source":{"system":"sec-edgar","filing":"0001140361-18-011289","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709639/000114036118011289/doc1.xml","form_type":"4"}}]}